Ashley Hall

Companies

• Structure Therapeutics Inc.Chief Development Officer Sep 20, 2024 to now¹
• OnKure Therapeutics, Inc.Chief Development Officer Oct 14, 2021 to Aug 29, 2023²
• Esperion TherapeuticsChief Development Officer Feb 28, 2020 to Jan 29, 2021³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• STStructure Therapeutics Inc. GPCR155,187 shares⁴$3.4M at $21.91Mar 19, 2026
• OTOnKure Therapeutics, Inc. OKUR39,600 shares⁵$85.3K at $2.15Aug 28, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 19, 2026Granted 47,706 shares of Structure Therapeutics Inc.⁴
• Mar 3, 2026Shares withheld for tax 4,836 shares at $20.99 of Structure Therapeutics Inc.⁶
• Sep 18, 2025Shares withheld for tax 6,021 shares at $7.74 of Structure Therapeutics Inc.⁷
• Mar 15, 2025Granted 51,048 shares of Structure Therapeutics Inc.⁸
• Sep 18, 2024Granted 67,290 shares of Structure Therapeutics Inc.⁹
• Aug 28, 2023Sold 15,625 shares at $6.28 of OnKure Therapeutics, Inc.⁵
• Aug 28, 2023Exercised options 15,625 shares at $1.80 of OnKure Therapeutics, Inc.⁵
• Nov 12, 2021Granted 30,000 shares of OnKure Therapeutics, Inc.¹⁰